CompletedNot Applicable

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Canada67 participantsStarted 2011-12

Plain-language summary

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Bleeding peptic ulcer Exclusion Criteria: * Patient is: \< 18 years of age * Patient is unable to consent * Patient is contraindicated to undergo endoscopy * Patient has: coagulopathy, altered post surgical anatomy of the stomach, previously placed intrahepatic portosystemic shunt * Patient is pregnant or lactating * Patinet has an INR \> 2.5

What they're measuring

Proportion of patients with further bleed

Timeframe: 72 Hours

Trial details

NCT IDNCT01306864

SponsorCook Group Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-04-30

View on ClinicalTrials.gov More Bleeding Peptic Ulcers trials